Cargando…
Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy
Doxorubicin (DOX) is one of the most effective chemotherapy agents used in the treatment of hematological and solid tumors, however, it causes dose-related cardiotoxicity that may lead to heart failure in patients. One of the major reasons was increased reactive oxygen species (ROS) production. Gins...
Autores principales: | Li, Lan, Ni, Jingyu, Li, Min, Chen, Jingrui, Han, Lifeng, Zhu, Yan, Kong, Deling, Mao, Jingyuan, Wang, Yi, Zhang, Boli, Zhu, Meifeng, Gao, Xiumei, Fan, Guanwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241051/ https://www.ncbi.nlm.nih.gov/pubmed/29063791 http://dx.doi.org/10.1080/10717544.2017.1391893 |
Ejemplares similares
-
Ginsenoside Rg3 ameliorates myocardial glucose metabolism and insulin resistance via activating the AMPK signaling pathway
por: Ni, Jingyu, et al.
Publicado: (2022) -
Ginsenoside Rg1 Prevents Doxorubicin-Induced Cardiotoxicity through the Inhibition of Autophagy and Endoplasmic Reticulum Stress in Mice
por: Xu, Zhi-Meng, et al.
Publicado: (2018) -
Ginsenoside Rg2 Attenuated Trastuzumab-Induced Cardiotoxicity in Rats
por: Liu, Guang, et al.
Publicado: (2022) -
The Essential Strategies to Mitigate Cardiotoxicity Caused by Doxorubicin
por: Chaulin, Aleksey Michailovich
Publicado: (2023) -
MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity
por: Kuang, Ziyu, et al.
Publicado: (2023)